Produces pharmaceutical-grade cannabis products for medical use.
Dec 2024Revenue ILS 239M/yrExpenses ILS 306M/yr
No trendCash runway ≈ 1.1 years from Dec 2024
Figures by year
When will Intercure be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2024, revenue was ILS 239M and expenses ILS 306M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2024 | ILS 239M | ILS 306M | −ILS 67.2M |
| Dec 2023 | ILS 356M | ILS 397M | −ILS 41.6M |
| Dec 2022 | ILS 389M | ILS 338M | ILS 50.6M |
| Dec 2021 | ILS 220M | ILS 191M | ILS 28.2M |
| Dec 2020 | ILS 65.0M | ILS 103M | −ILS 38.4M |
| Dec 2019 | ILS 8.93M | ILS 12.3M | −ILS 3.42M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.